NEW YORK, Sept 19 - Compugen (Nasdaq: CGEN) of Tel Aviv, Israel announced Tuesday the release of Z3, a high-throughput 2 dimensional gel electrophoresis analysis system, marking the company's first foray into the burgeoning proteomics market.

2D gel electrophoresis is the method of choice for separating complex mixtures of proteins, the first step in the typical proteomics research workflow. However, the 2D gel technique is only partially exploited due to difficulties in reproducing the technique and analyzing the results.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.